Cytox gets £800,00 from Innovate UK
Cytox has been awarded funding from Innovate UK for the clinical evaluation of its pioneering approach to Alzheimer’s disease risk assessment.
Read More
Tag: prognosis
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
